Advancing genomic medicine for rare diseases in Africa
Official title: African Rare Diseases Initiative (ARDI): Advancing Genomic Medicine through rare diseases research in Africa
Funded at Centre de Genetique Humaine · NIH-11084532 · Data updated 2026-11-12
This study is all about finding out more about rare diseases in Africa, especially in the Democratic Republic of Congo, so we can better understand them and help patients get the care they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Centre de Genetique Humaine NIH-funded |
| Lab location | 1 site (Lemba, Congo Dem Rep) |
| Project start | July 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $628,667 |
| NIH project number | 5R01HG012284-03 |
| Project ID | NIH-11084532 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in Africa, particularly those diagnosed with or suspected to have rare diseases.
✕Less likely to help
Patients outside of Africa or those with common diseases may not receive direct benefits from this research.
What this research studies
This research focuses on understanding and addressing rare diseases in Africa, particularly in the Democratic Republic of Congo. It aims to gather and analyze genomic data to identify the frequency and distribution of these diseases, which are often overlooked in global databases. By leveraging advancements in cloud technology and bioinformatics tools, the project seeks to improve diagnostic capabilities and patient care for those affected by rare diseases. The initiative also emphasizes the importance of community engagement and local advocacy in developing effective management strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients with rare diseases in Africa.
How similar studies have gone: Previous research has shown that increasing local genomic data can significantly enhance understanding and treatment of rare diseases, indicating a promising approach in this initiative.
Where this research is happening
-
Centre de Genetique Humaine
Lemba, Congo Dem Rep Active
Researchers
- Principal investigator: Lumaka Zola, Aime — Centre de Genetique Humaine
- Study coordinator: Lumaka Zola, Aime
Related research
Other NIH-funded projects on the same topics.
-
Liver pathobiology from rare liver diseases
A study at UCSF looks at why rare liver conditions cause liver damage, with the aim of finding new ways to diagnose and treat chronic liver disease.
-
Data Management and Coordinating Center support for Rare Diseases Research
A national rare diseases research program is funding a center to manage data and coordinate studies to help improve diagnosis, care, and potential treatments for children with rare conditions.
-
EEG-based drug repurposing for rare CNS diseases
A new approach uses EEG brain signatures to find existing drugs that might help people with rare nervous-system disorders.
-
Ethics of Engaging Patient Groups in Drug Development for Rare Diseases
This grant asks how patient and family groups can ethically help shape rare-disease drug development from idea to market, with input from patients, families, doctors, and researchers.
-
Center for Polyamine Disorders group study of rare metabolic disorders
A research consortium is studying a group of rare metabolic disorders linked to polyamines and aims to understand symptoms, biomarkers, and disease progression to improve care.
-
Encore: speeding up finding new uses for existing drugs to help kids with rare diseases
A big NIH project will test thousands of existing medicines to see if any can help treat rare genetic diseases in children.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.